PMO

Nucleic Acid Therapeutics, including ASOs, siRNAs, PMOs, mRNA, have enabled development of novel therapeutic options for disease targets previously considered un-druggable by conventional small molecule and biologics means.  While major advances and recent regulatory drug approvals have been made with liver and CNS, with ...